PMID: 16645461Apr 29, 2006Paper

Impact of hypothermia on the response to neuromuscular blocking drugs

Anesthesiology
T Heier, J E Caldwell

Abstract

Muscle strength is reduced during hypothermia, both in the presence and in the absence of neuromuscular blocking drugs. A 2 degrees C reduction in body temperature may double the duration of neuromuscular blockade. Central body and muscle temperatures decline in parallel, as long as peripheral vasoconstriction does not occur. A reduction in muscle strength must be expected at a body temperature less than 36 degrees C (corresponding to a muscle temperature of approximately 35 degrees C). Local cooling of the hand may make adductor pollicis twitch tension monitoring less useful during clinical anesthesia. The efficacy of neostigmine is maintained during mild hypothermia. The use of a nerve stimulator is strongly recommended to monitor the effect of neuromuscular blocking drugs during intraoperative hypothermia.

References

Jun 1, 1979·Anesthesiology·J Viby-MogensenH Ording
Nov 1, 1977·Anesthesiology·M J Laflin
Mar 1, 1979·Clinical Pharmacology and Therapeutics·L B SheinerJ Ham
Oct 1, 1992·Anesthesiology·D R BevanA F Kopman
Dec 1, 1992·Journal of Applied Physiology·B Bigland-RitchieJ J Woods
Jul 1, 1991·Acta Anaesthesiologica Scandinavica·L I ErikssonC Lennmarken
Jun 1, 1988·Anesthesiology·D I SesslerJ J Beebe
Sep 1, 1988·Anesthesiology·D I SesslerE H Rubinstein
Jul 1, 1987·Anesthesiology·D I SesslerE I Eger
Jul 1, 1967·The Journal of Physiology·W D Paton, D R Waud
Jan 1, 1972·The American Journal of Physiology·D WardT R Johns
Sep 1, 1974·European Journal of Pharmacology·J Zink, D Bose
Nov 1, 1983·Canadian Anaesthetists' Society Journal·M E FutterD R Bevan
Feb 1, 1982·British Journal of Anaesthesia·C J Hull
May 1, 1984·Clinical Pharmacology and Therapeutics·J S WalkerK F Brown
Jan 1, 1982·Pharmacology & Therapeutics·N H Holford, L B Sheiner
Jan 1, 1981·Anesthesia and Analgesia·L FarrellD R Waud
Jun 1, 1981·Anesthesia and Analgesia·R R Bartkowski, J C Horrow

❮ Previous
Next ❯

Citations

Nov 28, 2012·Journal of Anesthesia·Alan D KayeAmir R Baluch
Sep 28, 2012·Journal of Clinical Monitoring and Computing·Tod B Sloan
Mar 19, 2009·Journal of Neurotrauma·Donald Marion, M Ross Bullock
Jul 8, 2008·Annals of Cardiac Anaesthesia·Thomas M HemmerlingDavid Bracco
Aug 21, 2013·Saudi Journal of Anaesthesia·Mohamed Abdulatif
Oct 4, 2011·High Altitude Medicine & Biology·Hermann BruggerJeff Boyd
Apr 18, 2013·Critical Care Medicine·Steven B Greenberg, Jeffery Vender
Apr 9, 2011·Expert Opinion on Drug Metabolism & Toxicology·Jiangquan Zhou, Samuel M Poloyac
Jun 1, 2013·AORN Journal·Victoria M Steelman, Paula R Graling
Sep 30, 2010·Journal of Perianesthesia Nursing : Official Journal of the American Society of PeriAnesthesia Nurses·Shari M BurnsMary Wojnakowski
Jun 9, 2009·Journal of Perianesthesia Nursing : Official Journal of the American Society of PeriAnesthesia Nurses·Shari M BurnsGuy Caraffa
Jan 14, 2009·Best Practice & Research. Clinical Anaesthesiology·Juan-Manuel Campos, Pilar Paniagua
Sep 30, 2008·AORN Journal·Cynthia A Paulikas
Dec 17, 2015·Best Practice & Research. Clinical Anaesthesiology·Richard R RikerGilles L Fraser
May 31, 2007·AORN Journal·UNKNOWN AORN Recommended Practices Committee
Mar 20, 2015·Anesthesia and Analgesia·Aaron E BarryMartin J London
Sep 21, 2013·Anesthesiology·Christoph UnterbuchnerManfred Blobner
Jul 24, 2008·Anesthesiology·Daniel I Sessler
Jan 18, 2016·Lancet·Daniel I Sessler
Oct 19, 2016·Critical Care Medicine·Michael J MurraySangeeta Mehta
Jun 5, 2014·The Cochrane Database of Systematic Reviews·Phil AldersonSharon R Lewis
Nov 21, 2014·The Cochrane Database of Systematic Reviews·Sheryl WarttigAndrew F Smith
Nov 23, 2016·The Cochrane Database of Systematic Reviews·Sheryl WarttigAndrew F Smith
Apr 14, 2015·The Cochrane Database of Systematic Reviews·Gillian CampbellSheryl Warttig
Apr 22, 2016·The Cochrane Database of Systematic Reviews·Eva MadridPablo Alonso-Coello
Aug 2, 2018·Therapeutic Hypothermia and Temperature Management·Sarah L LivesayNicole Kupchik
Aug 8, 2017·Therapeutic Hypothermia and Temperature Management·Sarah LivesayPatricia A Blissitt
Sep 1, 2018·Health Technology Assessment : HTA·Peter Jd AndrewsGordon Murray
Apr 13, 2018·Minerva anestesiologica·Antonio CorcioneUNKNOWN Società Italiana di Anestesia Analgesia Rianimazione e Terapia Intensiva (SIAARTI) and Società Italiana di Chirurgia (SIC)
Jul 20, 2007·Acta Anaesthesiologica Scandinavica·T Fuchs-BuderUNKNOWN 8th International Neuromuscular Meeting
Jan 1, 2016·Journal of Perioperative Practice
Aug 16, 2019·PloS One·Alexandru TutunaruCharlotte Sandersen
Jun 5, 2012·Critical Care Nurse·Jason WilsonBrea O Rowan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.